# Tasigna Neoadjuvant Gastrointestinal Stromal Tumor (GIST)

> **NCT01270893** · PHASE2 · WITHDRAWN · sponsor: **M.D. Anderson Cancer Center**

## Conditions studied

- Gastrointestinal Cancer

## Interventions

- **DRUG:** Nilotinib

## Key facts

- **NCT ID:** NCT01270893
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2011-01
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No particapnt recruitment.
- **Last updated:** 2012-08-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01270893

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01270893, "Tasigna Neoadjuvant Gastrointestinal Stromal Tumor (GIST)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01270893. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*